Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Quest Pharmatech Inc V.QPT

Alternate Symbol(s):  QPTFF

Quest PharmaTech Inc. is a Canadian biopharmaceutical company. The Company is developing products to improve the quality of life. It is developing the proprietary, MAb-AR9.6, targeting MUC16 as a diagnostic agent for cancer. MAb-AR9.6 is licensed from the University of Nebraska Medical Centre and is in late preclinical stage development. The Company has a 42.5% ownership interest in OncoQuest Inc., which is a biotechnology company developing combinatorial immunotherapy products for the treatment of cancer. OncoQuest Inc.’s technology platform includes a panel of tumor antigen specific monoclonal antibodies of the immunoglobulin G (IgG) and E (IgE) class targeting CA125, MUC1, PSA, Her2/neu, CA 19.9 and TAG72; and the application of combinatorial immunotherapy to enhance tumor specific immunity and clinical outcome. The Company also has a 23% ownership interest in OncoVent, which is developing antibody-based immunotherapeutic products for cancer in the Greater China territory.


TSXV:QPT - Post by User

Comment by ARIMA11on Jan 07, 2021 6:16pm
121 Views
Post# 32250401

RE:RE:RE:RE:RE:update ...

RE:RE:RE:RE:RE:update ...
https://www.reuters.com/companies/078590.KQ
https://www.reuters.com/companies/QPT.V

Are we in the wrong stock? Is OQP really paying QPT?
Almost feel like its the other way around :) -jokes aside:

RE: Net from 300M/185M shares assume something like $1 per share. 

One thing that is a puzzle is if everyone is getting $1/share roughly (or even a little less), why would anyone sell? You'd think that the price would go up based on the fact that more shares would just means a bigger payment for a given shareholders.

Current Market Cap at 0.175 cents for 187M share is 32M. Oncoquest is getting 300M... :)
Ok. even 40% of that is 120M. Might be off somewhere here but something does not add up.

<< Previous
Bullboard Posts
Next >>